
UK pharma has concerns about the new NHS 10-year plan
The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.
Newsletters and Deep Dive digital magazine
The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.
After months of preparation and a drip-feed of some of its key features, the UK government has raised the curtain on its new 10-year plan for the NHS.
Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.
The UK government's Neighbourhood Health Service is central to the NHS 10 Year Plan - but can it deliver real change?
Finland's GlucoModicum thinks it is in the lead in the race to bring a non-invasive continuous glucose monitor (CGM) to market.
Editor's Picks
Newsletters and Deep Dive
digital magazine